Evidence map›Paper›PMID 30418976›Full record

Observational studyPLoS neglected tropical diseases2018

Exploring the parasite load and molecular diversity of Trypanosoma cruzi in patients with chronic Chagas disease from different regions of Brazil.

Ícaro Rodrigues-Dos-Santos, Myllena F Melo, Liane de Castro, Alejandro Marcel Hasslocher-Moreno, Pedro Emmanuel A A do Brasil, Andréa Silvestre de Sousa, Constança Britto, Otacilio C Moreira

Abstract readObservational Study
In one paragraph

Observational study in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Risk factors for vertical transmission of Chagas disease: A systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. International journal for parasitology. Parasites and wildlife · 2025
    Article
  9. Coinfection by multipleMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  10. Review
  11. Article
  12. Molecular Markers for the Phylogenetic Reconstruction ofPathogens (Basel, Switzerland) · 2025
    Review
  13. The epidemiology of Chagas disease in the Americas.Lancet regional health. Americas · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Molecular Characterization ofOpen forum infectious diseases · 2023
    Article
  18. Article
  19. Article
  20. Insights from the use of erythropoietin in experimental Chagas disease.International journal for parasitology. Drugs and drug resistance · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ícaro Rodrigues-Dos-SantosLaboratório de Biologia Molecular e Doenças Endêmicas, IOC /Fiocruz, Rio de Janeiro, Brazil.ORCID 0000-0001-5614-9443
Myllena F MeloLaboratório de Biologia Molecular e Doenças Endêmicas, IOC /Fiocruz, Rio de Janeiro, Brazil.
Liane de CastroLaboratório de Pesquisa Clínica em Doença de Chagas, INI/ Fiocruz, Rio de Janeiro, Brazil.
Alejandro Marcel Hasslocher-MorenoLaboratório de Pesquisa Clínica em Doença de Chagas, INI/ Fiocruz, Rio de Janeiro, Brazil.
Pedro Emmanuel A A do BrasilLaboratório de Pesquisa Clínica em Doença de Chagas, INI/ Fiocruz, Rio de Janeiro, Brazil.
Andréa Silvestre de SousaLaboratório de Pesquisa Clínica em Doença de Chagas, INI/ Fiocruz, Rio de Janeiro, Brazil.
Constança BrittoLaboratório de Biologia Molecular e Doenças Endêmicas, IOC /Fiocruz, Rio de Janeiro, Brazil.
Otacilio C MoreiraLaboratório de Biologia Molecular e Doenças Endêmicas, IOC /Fiocruz, Rio de Janeiro, Brazil.ORCID 0000-0002-5340-8697

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chagas disease is still a major public health issue in many Latin American countries. One of the current major challenges is to find an association between Trypanosoma cruzi discrete typing units (DTUs) and clinical manifestations of the disease. In this study, we used a multilocus conventional PCR and quantitative real time PCR (qPCR) approaches to perform the molecular typing and parasite load quantification directly from blood specimens of 65 chronic Chagas disease patients. All patients were recruited at the same health center, but their place of birth were widely distributed in different geographic regions of Brazil. Of the 65 patients, 35 (53.8%) presented positive amplification by real time qPCR, being 20 (30.7%) with the clinical indeterminate form and 15 (23.1%) with the cardiac form of the disease. The parasite load median for all positive patients was 2.54 [1.43-11.14] parasite equivalents/mL (par. Eq./mL), with the load ranging from 0.12 to 153.66 par. Eq./mL. Noteworthy, the parasite load was significantly higher in patients over 70 years old (median 20.05 [18.29-86.86] par. Eq./mL). Using guanidine-EDTA blood samples spiked with reference T. cruzi strains, belonging to the six DTUs, it was possible to genotype the parasite up to 0.5 par. Eq./mL, with high specificity. Of the patients with positive qPCR, it was possible to identify the T. cruzi DTU in 28 patients (80%). For the remaining patients (20%), at least a partial result was obtained. Analysis of specimens showed prevalences of TcVI, TcII and mixed infection TcVI+TcII equal to 40%, 17.1% and 14.3%, respectively. In addition, two patients were infected by TcV, and one patient was coinfected by TcIII+TcVI, These last three patients were in stage A of chronic chagasic cardiomyopathy (CCC), and they were born at the Bahia State (northeast region of Brazil). When T. cruzi genotypes were compared with the parasite load, more elevated parasite loads were observed in patients infected by TcII in general (parasite load median of 7.56 par. Eq./mL) in comparison to patients infected by TcVI (median of 2.35 par. Eq./mL). However, while the frequency of CCC was 50% in patients infected by TcVI and TcV, only 16.7% of patients infected by TcII evolved to CCC. Taking together, our results contribute to update the epidemiological knowledge of T. cruzi DTUs in Brazil, and highlight the age of patient and infection by TcII as important features that lead to the observation of higher parasitemia levels.

Indexed as

Genetic VariationAgedBrazilChagas DiseaseCoinfectionCross-Sectional StudiesDNA, ProtozoanFemaleGenotypeHumansMaleMiddle AgedMolecular TypingParasite LoadParasitemiaReal-Time Polymerase Chain ReactionDNA, Protozoan

Identifiers

PMID30418976
PMCPMC6258420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.